Quick Answer
BIOXYTRAN, INC reported Stockholders Equity of -$3.16 million for the year ending 2021.
- BIOXYTRAN, INC showed a decrease of -62.7% in Stockholders Equity from 2020 to 2021.
- This data is from BIOXYTRAN, INC's annual report (Form 10-K), filed with the SEC on April 11, 2022.
- XBRL data for this metric is available from 2010 to 2021 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$174.7 thousand | Q3 2013: -$451.9 thousand | Q1 2014: $138.2 thousand | Q2 2014: -$10.6 thousand | Q3 2014: -$76.9 thousand | Q1 2015: -$260.5 thousand | Q2 2015: -$286.5 thousand | Q3 2015: -$80.3 thousand | Q1 2016: -$226.3 thousand | Q2 2016: -$211.9 thousand | Q3 2016: -$260.9 thousand | Q1 2017: -$355.2 thousand | Q2 2017: -$393.8 thousand | Q3 2017: -$345.0 thousand | Q1 2018: $512.8 thousand | Q2 2018: $536.1 thousand | Q3 2018: -$49.8 thousand | Q1 2019: -$654.9 thousand | Q2 2019: -$656.9 thousand | Q3 2019: -$1.18 million | Q1 2020: -$1.84 million | Q2 2020: -$1.90 million | Q3 2020: -$2.09 million | Q4 2020: -$1.94 million | Q1 2021: -$2.49 million | Q2 2021: -$1.31 million | Q3 2021: -$1.92 million | Q4 2021: -$3.16 million | Q1 2022: -$4.08 million | Q2 2022: -$4.76 million.
- Over the full 12 years of available data (2010 to 2021), BIOXYTRAN, INC's Stockholders Equity has declined by 5,537.8%.
- Historical annual values: Fiscal year 2021: -$3.16 million | Fiscal year 2020: -$1.94 million | Fiscal year 2019: -$799.3 thousand | Fiscal year 2018: -$225.3 thousand | Fiscal year 2017: -$1.3 thousand | Fiscal year 2016: -$290.6 thousand | Fiscal year 2015: -$195.2 thousand | Fiscal year 2014: -$221.5 thousand | Fiscal year 2013: $75.4 thousand | Fiscal year 2012: $354.1 thousand | Fiscal year 2011: $163.3 thousand | Fiscal year 2010: -$56.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: